Immune Infiltration Characteristics and a Gene Prognostic Signature Associated With the Immune Infiltration in Head and Neck Squamous Cell Carcinoma

Background: Immunotherapy has become the new standard of care for recurrent and metastatic head and neck squamous cell carcinoma (HNSCC), and PD-L1 is a widely used biomarker for immunotherapeutic response. However, PD-L1 expression in most cancer patients is low, and alternative biomarkers used to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Chunmei, Wu, Qiuji, Yang, Ningning, Zheng, Zhewen, Zhou, Fuxiang, Zhou, Yunfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108548/
https://www.ncbi.nlm.nih.gov/pubmed/35586567
http://dx.doi.org/10.3389/fgene.2022.848841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108548/
https://www.ncbi.nlm.nih.gov/pubmed/35586567
http://dx.doi.org/10.3389/fgene.2022.848841

Ejemplares similares